<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000048" GROUP_ID="NEONATAL" ID="673699082215081092" MERGED_FROM="" MODIFIED="2013-02-25 19:59:39 +0000" MODIFIED_BY="Diane Haughton" NOTES="&lt;p&gt;Exported from Review Manager 4.2.2&lt;br&gt;Short title (no longer in use): Caffeine to prevent postoperative apnea in preterm&lt;/p&gt;&lt;p&gt;CL 3/04 update&lt;/p&gt;&lt;p&gt;&lt;br&gt;sent to Loni Mar 29/07&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2012-04-18 14:18:11 -0400" NOTES_MODIFIED_BY="Diane Haughton" REVIEW_NO="005" REVMAN_SUB_VERSION="5.1.6" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.0">
<COVER_SHEET MODIFIED="2013-02-25 19:59:39 +0000" MODIFIED_BY="Diane Haughton">
<TITLE MODIFIED="2011-01-14 01:08:14 -0500" MODIFIED_BY="[Empty name]">Prophylactic caffeine to prevent postoperative apnoea following general anaesthesia in preterm infants</TITLE>
<CONTACT MODIFIED="2013-02-25 19:59:39 +0000" MODIFIED_BY="Diane Haughton"><PERSON ID="5306" ROLE="AUTHOR"><PREFIX>Mrs</PREFIX><FIRST_NAME>Diane</FIRST_NAME><LAST_NAME>Haughton</LAST_NAME><POSITION>Managing Editor, Cochrane Neonatal Group</POSITION><EMAIL_1>haughton@mcmaster.ca</EMAIL_1><URL>http://cochrane.mcmaster.ca/neonatal/</URL><ADDRESS><DEPARTMENT>Department of Pediatrics and Clinical Epidemiology and Biostatistics</DEPARTMENT><ORGANISATION>McMaster University</ORGANISATION><ADDRESS_1>1280 Main Street West</ADDRESS_1><ADDRESS_2>CRL, Room B102</ADDRESS_2><CITY>Hamilton</CITY><ZIP>L8S 4K1</ZIP><REGION>Ontario</REGION><COUNTRY CODE="CA">Canada</COUNTRY><PHONE_1>+1 905 525 9140 ext: 22897</PHONE_1><FAX_1>+1 905 521 5007</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2013-02-25 19:59:39 +0000" MODIFIED_BY="Diane Haughton"><PERSON ID="4691" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>David</FIRST_NAME><MIDDLE_INITIALS>J</MIDDLE_INITIALS><LAST_NAME>Henderson-Smart</LAST_NAME><ADDRESS><DEPARTMENT>(Deceased) Central Clinical School</DEPARTMENT><ORGANISATION>Faculty of Medicine, University of Sydney</ORGANISATION><CITY>Sydney</CITY><COUNTRY CODE="AU">Australia</COUNTRY></ADDRESS></PERSON><PERSON ID="18344" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Peter</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Steer</LAST_NAME><SUFFIX>MB, BS, FRACP, FRCPC,FAAP</SUFFIX><POSITION>Professor and Chief Executive Officer</POSITION><EMAIL_1>Peter_Steer@health.qld.gov.au</EMAIL_1><ADDRESS><DEPARTMENT>School of Medicine, Faculty of Health Sciences, University of Queensland</DEPARTMENT><ORGANISATION>Children's Health Services District, Queensland Health</ORGANISATION><CITY>Brisbane</CITY><ZIP>L8N 3Z5</ZIP><REGION>Queensland</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>0409 639682</PHONE_1><FAX_1>7 3895 3221</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2011-01-18 19:32:39 -0500" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Minor update: 18/02/04&lt;/p&gt;&lt;p&gt;New studies sought but none found: 16/07/08&lt;/p&gt;&lt;p&gt;Reformatted: 04/09/99&lt;/p&gt;" NOTES_MODIFIED="2011-01-18 19:32:39 -0500" NOTES_MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="19" MONTH="1" YEAR="2011"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="16" MONTH="1" YEAR="2011"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="19" MONTH="1" YEAR="2013"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="1996"/>
<REVIEW_PUBLISHED ISSUE="3" YEAR="1997"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2001"/>
</DATES>
<WHATS_NEW MODIFIED="2013-02-25 19:59:39 +0000" MODIFIED_BY="Diane Haughton" NOTES="&lt;p&gt;This updates the existing review of &amp;quot;Prophylactic caffeine to prevent postoperative apnea following general anaesthesia in preterm infants&amp;quot; which was last updated in July 2004 (Henderson-Smart 2004). The search for trials was repeated in July 2008. No new trials were found.&lt;/p&gt;" NOTES_MODIFIED="2012-04-18 14:18:11 -0400" NOTES_MODIFIED_BY="[Empty name]"><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-02-25 19:59:39 +0000" MODIFIED_BY="Diane Haughton"><DATE DAY="25" MONTH="2" YEAR="2013"/><DESCRIPTION><P>Contact details updated.</P></DESCRIPTION></WHATS_NEW_ENTRY>

</WHATS_NEW>
<HISTORY MODIFIED="2013-02-25 19:59:39 +0000" MODIFIED_BY="Diane Haughton"><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-02-25 19:59:39 +0000" MODIFIED_BY="Diane Haughton">
<DATE DAY="18" MONTH="4" YEAR="2012"/>
<DESCRIPTION>
<P>Contact person changed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-04-18 14:17:55 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="19" MONTH="1" YEAR="2011"/>
<DESCRIPTION>
<P>This updates the review "Prophylactic caffeine to prevent postoperative apnoea following general anaesthesia in preterm infants" (<LINK REF="REF-Henderson_x002d_Smart-2004" TYPE="REFERENCE">Henderson-Smart 2004</LINK>).</P>
<P>Search updated in January 2011. One new related reference (<LINK REF="REF-Krane-1995" TYPE="REFERENCE">Krane 1995</LINK>) has been added to additional references and the risk of bias tables have been completed.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2010-12-07 12:19:25 -0500" MODIFIED_BY="Diane Haughton">
<DATE DAY="15" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>This updates the review "Prophylactic caffeine to prevent postoperative apnea following general anesthesia in preterm infants" published in the Cochrane Database of Systematic Reviews, Issue 2, 2004 (Henderson-Smart 2004).</P>
<P>Updated search in July 2008 found no new eligible trials for inclusion.</P>
<P>No changes to conclusions.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-12-07 12:19:25 -0500" MODIFIED_BY="Diane Haughton">
<DATE DAY="15" MONTH="7" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-09-17 13:38:14 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="18" MONTH="2" YEAR="2004"/>
<DESCRIPTION>
<P>This updates the existing review of "Prophylactic caffeine to prevent postoperative apnea following general anaesthesia in preterm infants" which was last updated in July 2001 (Henderson-Smart 2001). The search for trials was repeated in January 2004. No new trials were found. Two new additional references have been added. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="16" MONTH="7" YEAR="2001"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2011-01-19 04:36:20 -0500" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2011-01-19 04:36:20 -0500" MODIFIED_BY="[Empty name]">
<SOURCE>
<NAME>NSW Centre for Perinatal Health Services Research, Sydney</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Royal Prince Alfred Hospital, Sydney</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2011-01-19 04:35:59 -0500" MODIFIED_BY="[Empty name]">
<NAME>School of Medicine, Faculty of Health Sciences, University of Queensland, Children's Health Services District, Queensland Health, Brisbane</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION>
<P>Co-author</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2011-06-15 11:01:48 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2011-01-14 01:09:09 -0500" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2011-01-14 01:08:55 -0500" MODIFIED_BY="[Empty name]">Prophylactic caffeine to prevent postoperative apnoea following general anaesthesia in preterm infants</TITLE>
<SUMMARY_BODY MODIFIED="2011-01-14 01:09:09 -0500" MODIFIED_BY="[Empty name]">
<P>Caffeine may be able to prevent postoperative apnoea and bradycardia in preterm babies. Growing babies who were born too early (preterm) and who undergo general anaesthetic for surgery may have complications, including episodes of apnoea (pauses in breathing), cyanosis (from lack of oxygen in the blood), and bradycardia (slow heartbeat). Caffeine, a methylxanthine drug, is thought to stimulate breathing, and so possibly prevent apnoea and subsequent problems. The review found some evidence that caffeine given at the time of surgery reduces apnoea, bradycardia, and cyanosis after anaesthetic, but the importance of this is unclear.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2011-06-15 10:52:56 -0400" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2011-01-14 01:08:26 -0500" MODIFIED_BY="[Empty name]">
<P>Growing ex-preterm infants who undergo general anaesthesia for surgery at about term-equivalent age may have episodes of apnoea, cyanosis and bradycardia during the early postoperative period. A breathing stimulant such as caffeine given at the time of operation might prevent these episodes.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2011-01-14 01:08:36 -0500" MODIFIED_BY="[Empty name]">
<P>To determine the effect of the prophylactic use of caffeine to prevent episodes of apnoea, cyanosis and bradycardia during the postoperative period in ex-preterm infants who undergo general anaesthesia for surgery.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2011-06-15 10:52:56 -0400" MODIFIED_BY="[Empty name]">
<P>The standard strategy of the Neonatal Review Group was used. This included searches of the <I>The Cochrane Library</I>, Oxford Database of Perinatal Trials, MEDLINE, EMBASE, CINAHL and abstracts of the Society for Pediatric Research. Seach updated in January 2011.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2008-09-17 13:52:52 -0400" MODIFIED_BY="[Empty name]">
<P>All trials utilising random or quasi-random patient allocation, in which treatment was compared with placebo or no treatment were included.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2011-03-28 20:15:52 -0400" MODIFIED_BY="[Empty name]">
<P>The standard methods of the Cochrane Collaboration and its Neonatal Review Group were used to select trials, evaluate trial quality and to extract data. Each review author extracted data separately, and then compared and resolved any differences. Meta-analysis used relative risk and risk difference.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2011-06-05 17:42:20 -0400" MODIFIED_BY="[Empty name]">
<P>Three eligible trials were found. In each trial apnoea/bradycardia occurred in fewer infants treated with caffeine. The typical estimate for relative risk is 0.09 (95% CI 0.02 to 0.34). The typical estimate for absolute risk difference is -0.58 (95% CI -0.74 to -0.43) indicating that fewer than two infants have to be treated with caffeine to expect to prevent one with postoperative apnoea. In two trials (Welborn 1989; LeBard 1989), continuous recordings of oxygen saturation detected hypoxaemic episodes (&lt; 90%) in fewer treatment than control infants [typical RR 0.13 (95% CI 0.03 to 0.63)]. No infant in any trial required intubation and mechanical ventilation. No adverse effects were reported.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2011-03-28 20:17:19 -0400" MODIFIED_BY="[Empty name]">
<P>Implications for practice. After general anaesthesia, caffeine can be used to prevent postoperative apnoea/bradycardia and episodes of oxygen desaturation in growing preterm infants if this is deemed clinically necessary. In view of the small numbers of infants studied in these trials and uncertainty concerning the clinical significance of the episodes, caution is warranted in applying these results to routine clinical practice.</P>
<P>Implications for research. There is a need to determine which infants might benefit most by this treatment. Studies confined to those most at risk of apnoea (prior history, younger postmenstrual age) and those that might require mechanical ventilation or chronic lung disease would be of value.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2011-06-15 11:01:48 -0400" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2011-03-28 20:21:41 -0400" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2011-03-28 20:20:41 -0400" MODIFIED_BY="[Empty name]">
<P>Growing ex-preterm infants who undergo general anaesthesia for surgery at about term equivalent age may have episodes of apnoea, cyanosis and bradycardia during the early postoperative period.</P>
<P>The American Academy of Pediatrics defined infant apnoea as a pause in breathing of greater than 20 seconds, or one of less than 20 seconds and associated with bradycardia and/or cyanosis (<LINK REF="REF-AAP-2003" TYPE="REFERENCE">AAP 2003</LINK>). Recurrent episodes of apnoea are common in preterm infants and the incidence and severity increases at lower gestational ages. By term equivalent postnatal age infants have usually 'outgrown' their tendency to spontaneous apnoea. However, if some additional insult such as infection, or the administration of drugs that depress the central nervous system occurs (such as general anaesthetic agents, <LINK REF="REF-Liu-1983" TYPE="REFERENCE">Liu 1983</LINK>), apnoea and associated oxygen desaturations can recur. Attempts have been made to determine which infants are most at risk (<LINK REF="REF-Cote-1995" TYPE="REFERENCE">Cote 1995</LINK>; <LINK REF="REF-Spear-1992" TYPE="REFERENCE">Spear 1992</LINK>; <LINK REF="REF-Welborn-1994" TYPE="REFERENCE">Welborn 1994</LINK>). Factors such as younger postmenstrual age and past history of apnoea seem important, although such risk scoring does not detect all infants who develop postanaesthesia problems (<LINK REF="REF-Cote-1995" TYPE="REFERENCE">Cote 1995</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2011-01-14 01:10:47 -0500" MODIFIED_BY="[Empty name]">
<P>Methylxanthines such as caffeine are thought to stimulate breathing efforts and have been used in clinical practice to reduce apnoea in preterm infants since the late 1970's. Caffeine is better than theophylline in other attempts to reduce apnoea.</P>
</INTERVENTION>
<THEORY MODIFIED="2011-03-28 20:21:41 -0400" MODIFIED_BY="[Empty name]">
<P>The mechanism of their action is not certain. Possibilities include increased chemoreceptor responsiveness (based on increased breathing responses to CO2), enhanced respiratory muscle performance and generalised central nervous system excitation. Other reviews on the effects of methylxanthines such as caffeine on apnoea, published in <I>The Cochrane Library</I>, include <LINK REF="REF-Henderson_x002d_Smart-a" TYPE="REFERENCE">Henderson-Smart a</LINK>; <LINK REF="REF-Henderson_x002d_Smart-b" TYPE="REFERENCE">Henderson-Smart b</LINK>; <LINK REF="REF-Henderson_x002d_Smart-c" TYPE="REFERENCE">Henderson-Smart c</LINK> and <LINK REF="REF-Henderson_x002d_Smart-d" TYPE="REFERENCE">Henderson-Smart d</LINK>. A systematic review has also been carried out on the effects of regional versus general anaesthesia on postoperative apnoea (<LINK REF="REF-Craven-2003" TYPE="REFERENCE">Craven 2003</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2011-01-20 23:14:14 -0500" MODIFIED_BY="[Empty name]">
<P>If prolonged, apnoea can lead to hypoxaemia and reflex bradycardia which may require active resuscitative efforts to reverse. There are clinical concerns that these episodes might be harmful to the developing brain or cause dysfunction of the gastrointestinal tract or other organs, although there are no data to support this. Frequent episodes may be accompanied by respiratory failure of sufficient severity as to lead to intubation and the use of intermittent positive pressure ventilation (IPPV).</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2011-01-20 23:14:44 -0500" MODIFIED_BY="[Empty name]">
<P>To determine the effect of the prophylactic use of caffeine on episodes of apnoea, cyanosis and bradycardia during the postoperative period in ex-preterm infants who undergo general anaesthesia for surgery.</P>
</OBJECTIVES>
<METHODS MODIFIED="2011-06-15 10:56:38 -0400" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2011-04-11 10:36:43 -0400" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2008-09-17 13:57:38 -0400" MODIFIED_BY="[Empty name]">
<P>Trials utilising random or quasi-random patient allocation.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2011-01-20 23:14:58 -0500" MODIFIED_BY="[Empty name]">
<P>Preterm infants undergoing general anaesthesia for surgery at about term equivalent age.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2011-01-20 23:15:08 -0500" MODIFIED_BY="[Empty name]">
<P>Caffeine given with general anaesthesia, compared with control, as prophylaxis for postoperative apnoea.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2011-04-11 10:36:43 -0400" MODIFIED_BY="[Empty name]">
<OL>
<LI>Episodes of apnoea and bradycardia consistent with clinical apnoea (<LINK REF="REF-AAP-2003" TYPE="REFERENCE">AAP 2003</LINK>).</LI>
<LI>Episodes of oxygen desaturation (&gt; 10% fall).</LI>
<LI>Use of IPPV.</LI>
<LI>Side effects.</LI>
</OL>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2011-06-15 10:55:52 -0400" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2011-06-15 10:55:52 -0400" MODIFIED_BY="[Empty name]">
<P>We used the standard strategy of the Neonatal Review Group. We searched the Cochrane Central Register of Controlled Trials (CENTRAL, <I>The Cochrane Library January 2011</I>, MEDLINE (1966 to January 2011), EMBASE (1980 to January 2011), CINAHL (1982 to January 2011). Search terms included text words 'apnoea', 'caffeine' and MeSH heading 'infant, premature'. We also searched previous reviews including cross references. We searched abstracts of the Society for Pediatric Research for the years 1996 to 2010 inclusive.</P>
<P>Clinical trials registries were also searched for ongoing or recently completed trials (clinicaltrials.gov; controlled-trials.com; and who.int/ictrp/en).</P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2011-06-15 10:56:38 -0400" MODIFIED_BY="[Empty name]">
<P>The standard methods of the Cochrane Collaboration and its Neonatal Review Group were used to select trials, evaluate the quality of the trials and to extract data. </P>
<STUDY_SELECTION MODIFIED="2011-06-14 09:18:46 -0400" MODIFIED_BY="[Empty name]">
<P>The reviewers independently assessed for all the potential studies identified as a result of the search strategy for possible inclusion. The title and abstract of each retrieved study were examined. If there was uncertainty, the full paper was examined. Disagreements were resolved by discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2011-06-05 17:48:56 -0400" MODIFIED_BY="[Empty name]">
<P>Each review author extracted data separately and then compared and resolved differences.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2011-06-15 10:56:38 -0400" MODIFIED_BY="[Empty name]">
<P>We used the standard review methods of the CNRG (<A HREF="http://neonatal.cochrane.org/en/index.html">http://neonatal.cochrane.org/en/index.html</A>) to assess the methodological quality of included studies. Review authors independently assessed study quality and risk of bias using the following criteria documented in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>1) Sequence generation: was the allocation sequence adequately generated?</P>
<P>2) Allocation concealment: was allocation adequately concealed?</P>
<P>3) Blinding of participants, personnel and outcome assessors for each main outcome or class of outcomes: was knowledge of the allocated intervention adequately prevented during the study?</P>
<P>4) Incomplete outcome data for each main outcome or class of outcomes: were incomplete outcome data adequately addressed?</P>
<P>5) Selective outcome reporting: are reports of the study free of suggestion of selective outcome reporting?</P>
<P>6) Other sources of bias: was the study apparently free of other problems that could put it at a high risk of bias? We gave particular attention to completeness of follow-up of all randomised infants and to the length of follow-up studies to identify whether any benefits claimed are robust.</P>
<P>When necessary, we requested additional information and clarification of published data from the authors of individual trials. We assessed each trial for risk of bias based on the criteria listed above and marked as:</P>
<P>a) low risk of bias;</P>
<P>b) unclear risk of bias;</P>
<P>c) high risk of bias.</P>
<P>We resolved any discrepancies by mutual discussion and consensus. We planned to provide information on levels of agreement between review authors and/or details of resolution of differences.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2011-06-14 09:19:14 -0400" MODIFIED_BY="[Empty name]">
<P>The standard methods of the Neonatal Review Group were used. Statistical analyses were performed using Review Manager software. Categorical data were analysed using relative risk (RR), risk difference (RD) and the number needed to treat (NNT). Continuous data were analysed using weighted mean difference (WMD). The 95% Confidence interval (CI) was reported on all estimates.</P>
</EFFECT_MEASURES>
<HETEROGENEITY_ASSESSMENT MODIFIED="2011-06-14 09:19:07 -0400" MODIFIED_BY="[Empty name]">
<P>We assessed statistical heterogeneity in each meta-analysis using the I² and Chi² statistics. We regarded heterogeneity to be substantial if either I² was greater than 50% or there was a low P-value (less than 0.10) in the Chi² test for heterogeneity.</P>
<P>If we detected statistical heterogeneity, we planned to explore the possible causes (for example, differences in study quality, participants, intervention regimens, or outcome assessments) using post hoc sub group analyses.</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2011-06-05 18:02:25 -0400" MODIFIED_BY="[Empty name]">
<P>Meta-analysis was performed using Review Manager software (RevMan 5) supplied by the Cochrane Collaboration. For estimates of typical relative risk and risk difference, we used the Mantel-Haenszel method. For measured quantities, we used the inverse variance method. All meta-analyses were done using the fixed effect model.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2011-06-05 17:45:47 -0400" MODIFIED_BY="[Empty name]">
<P>No subgroup analyses were planned.</P>
</SUBGROUP_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2011-06-15 11:01:48 -0400" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2011-06-15 11:01:48 -0400" MODIFIED_BY="[Empty name]">
<P>Three eligible trials were found. Details are given in the table 'Characteristics of included studies'. In general, infants were born at 30 to 32 weeks gestation and studied at 40 to 44 weeks postmenstrual age. All three trials evaluated caffeine given intravenously in a single dose during general anaesthesia. The dosage varied from 5 mg/kg (<LINK REF="STD-Welborn-1988" TYPE="STUDY">Welborn 1988</LINK>) to 10 mg/kg (<LINK REF="STD-LeBard-1989" TYPE="STUDY">LeBard 1989</LINK>; <LINK REF="STD-Welborn-1989" TYPE="STUDY">Welborn 1989</LINK>). In all three trials apnoea was defined as any apnoeic episodes of &gt; 15 seconds duration, or shorter ones associated with bradycardia. In two trials, oxygen desaturations (&lt; 90%) on pulse oximetry were recorded (<LINK REF="STD-LeBard-1989" TYPE="STUDY">LeBard 1989</LINK>; <LINK REF="STD-Welborn-1989" TYPE="STUDY">Welborn 1989</LINK>).</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2011-03-28 20:28:54 -0400" MODIFIED_BY="[Empty name]">
<P>This is detailed in the table 'Characteristics of included studies'.</P>
<P>Concealment at randomisation: all used formal randomisation, although the steps taken to fully conceal allocation assignment were not clear.<BR/>
<BR/>Blinding of treatment: in each trial a saline placebo was used.</P>
<P>Blinding of outcome assessment: in two trials apnoea/bradycardia was assessed blindly from a polygraphic recording. Methodology in the third trial (<LINK REF="STD-LeBard-1989" TYPE="STUDY">LeBard 1989</LINK>) needs clarification as this has only been published in abstract form.</P>
<P>Completeness of follow-up: not clearly stated.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2011-06-05 17:43:23 -0400" MODIFIED_BY="[Empty name]">
<P>Three eligible trials were found. In each trial apnoea/bradycardia occurred in fewer infants treated with caffeine. The typical estimate for relative risk is 0.09 (95% CI 0.02 to 0.34). Absolute risk difference is -0.58 (95% CI -0.74 to -0.43) indicating that fewer than two infants have to be treated with caffeine to expect to prevent one with postoperative apnoea. In two trials (<LINK REF="STD-LeBard-1989" TYPE="STUDY">LeBard 1989</LINK>; <LINK REF="STD-Welborn-1989" TYPE="STUDY">Welborn 1989</LINK>) continuous recordings of oxygen saturation detected hypoxaemic episodes (&lt; 90%) in fewer treatment than control infants [RR 0.13 (95% CI 0.03 to 0.63]. No infant in any trial required intubation and mechanical ventilation. No adverse effects were reported.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2011-03-28 20:31:15 -0400" MODIFIED_BY="[Empty name]">
<P> </P>
<SUMMARY_OF_RESULTS MODIFIED="2011-01-19 04:38:06 -0500" MODIFIED_BY="[Empty name]">
<P>Caffeine reduces the occurrence of apnoea, bradycardia and oxygen desaturation after general anaesthesia, although it has yet to be determined whether these episodes are clinically important. If such episodes are detected by monitors, responded to promptly by nurses and do not lead to a need for mechanical ventilation, then these episodes are of uncertain significance. Apnea and hypoxaemia might be more important in infants at particularly high risk of respiratory failure, such as those with chronic lung disease. This has not been evaluated.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2011-01-19 04:42:30 -0500" MODIFIED_BY="[Empty name]">
<P>No adverse effects of caffeine were reported, although the number of infants studied in these three trials is too small to exclude less common ones.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2011-01-19 04:45:58 -0500" MODIFIED_BY="[Empty name]">
<P>One trial (<LINK REF="STD-LeBard-1989" TYPE="STUDY">LeBard 1989</LINK>) have many unclear methodology and was only published as an abstract. The other two trials had good methodology.</P>
</QUALITY_OF_EVIDENCE>
<AGREEMENT MODIFIED="2011-03-28 20:31:15 -0400" MODIFIED_BY="[Empty name]">
<P>Two randomised trials (<LINK REF="REF-Krane-1995" TYPE="REFERENCE">Krane 1995</LINK>; <LINK REF="REF-Welborn-1990" TYPE="REFERENCE">Welborn 1990</LINK>) have suggested that apnoea is more common following general anaesthesia than following spinal anaesthesia without premedication in infants having inguinal hernia repair, one of the most common operative procedures in ex-preterm infants. A Cochrane review (<LINK REF="REF-Craven-2003" TYPE="REFERENCE">Craven 2003</LINK>) did not find evidence to support that hypothesis.</P>
<P>Variations in the type of general anaesthetic agents might affect postoperative ventilatory function. A trial (<LINK REF="REF-Sale-2006" TYPE="REFERENCE">Sale 2006</LINK>) compared two general anaesthetic agents (desflurane and sevoflurane) in terms of postoperative ventilatory events or in the number of apneas in the postoperative period and found no difference</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2011-01-20 23:25:04 -0500" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2011-01-20 23:24:57 -0500" MODIFIED_BY="[Empty name]">
<P>After general anaesthesia caffeine can be used to prevent postoperative apnoea/bradycardia and episodes of oxygen desaturation in preterm infants if this is deemed clinically necessary. In view of the small numbers of infants studied in these trials and uncertainty concerning the clinical significance of the episodes, caution is warranted in applying these results to routine clinical practice.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2011-01-20 23:25:04 -0500" MODIFIED_BY="[Empty name]">
<P>There is a need to determine which infants might benefit most by this treatment. Studies confined to those most at risk of apnoea (prior history, younger postmenstrual age) and those that might require mechanical ventilation (chronic lung disease) would be of value.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2011-03-28 20:40:45 -0400" MODIFIED_BY="[Empty name]">
<P>Editorial support of the Cochrane Neonatal Review Group has been funded with Federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN267200603418C.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None<BR/> </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-07-31 07:08:15 -0400" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;The original protocol and review were done by Henderson-Smart and Steer. The current update was done by Henderson-Smart and approved by Steer.&lt;/p&gt;" NOTES_MODIFIED="2008-07-31 07:08:15 -0400" NOTES_MODIFIED_BY="[Empty name]">
<P>The original protocol and review were done by Henderson-Smart and Steer. The current update was done by Henderson-Smart and approved by Steer.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2011-06-15 10:59:26 -0400" MODIFIED_BY="[Empty name]">
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-LeBard-1989" NAME="LeBard 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>LeBard SE, Kurth CD, Spitzer AR, Downes JJ</AU>
<TI>Preventing postoperative apnea by neuromodulator antagonists</TI>
<SO>Anesthesiology</SO>
<YR>1989</YR>
<VL>71</VL>
<PG>A1026</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Welborn-1988" NAME="Welborn 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Welborn LG, De Soto H, Hannallah RS, Fink R, Ruttimann UE, Boeckx R. The use of caffeine in the control of post-anesthetic apnea in former premature infants. Anesthesiology 1988;68:796-798.&lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Welborn LG, De Soto H, Hannallah RS, Fink R, Ruttimann UE, Boeckx R</AU>
<TI>The use of caffeine in the control of post-anesthetic apnea in former premature infants</TI>
<SO>Anesthesiology</SO>
<YR>1988</YR>
<VL>68</VL>
<PG>796-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Welborn-1989" NAME="Welborn 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Welborn LG, Hannallah RS, Fink R, Ruttimann UE, Hicks JM. High-dose caffeine suppresses postoperative apnea in former preterm infants. Anesthesiology 1989;71:347-349.&lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Welborn LG, Hannallah RS, Fink R, Ruttimann UE, Hicks JM</AU>
<TI>High-dose caffeine suppresses postoperative apnea in former preterm infants</TI>
<SO>Anesthesiology</SO>
<YR>1989</YR>
<VL>71</VL>
<PG>347-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES/>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2011-06-15 10:59:26 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2011-06-15 10:59:26 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-AAP-2003" NAME="AAP 2003" NOTES="&lt;p&gt;American Academy of Pediatrics, Policy statement. Apnea, Sudden Infant Death Syndrome, and home monitoring. Pediatrics 2003; 111:914-917.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>American Academy of Pediatrics</AU>
<TI>Policy statement. Apnea, Sudden Infant Death Syndrome, and home monitoring</TI>
<SO>Pediatrics</SO>
<YR>2003</YR>
<VL>111</VL>
<PG>914-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cote-1995" NAME="Cote 1995" NOTES="&lt;p&gt;Cote CJ, Zaslavsky A, Downes JJ, Kurth CD, Welborn LG, Warner LO, Malviya SVM. Postoperative apnea in former preterm infants after inguinal herniorrhophy. Anesthesiology 1995, 82:809-822.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Cote CJ, Zaslavsky A, Downes JJ, Kurth CD, Welborn LG, Warner LO, Malviya SV</AU>
<TI>Postoperative apnea in former preterm infants after inguinal herniorrhaphy</TI>
<SO>Anesthesiology</SO>
<YR>1995</YR>
<VL>82</VL>
<PG>809-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Craven-2003" MODIFIED="2008-08-15 10:50:04 -0400" MODIFIED_BY="[Empty name]" NAME="Craven 2003" NOTES="&lt;p&gt;Craven PD, Badawi N, Henderson-Smart DJ, O'Brien M. Regional (spinal, epidural, caudal) versus general anaesthesia in preterm infants undergoing inguinal herniorrhaphy in early infancy (Cochrane Review). In: The Cochrane Library, Issue 4, 2003. Chichester, UK: John Wiley &amp;amp; Sons, Ltd.&lt;/p&gt;" NOTES_MODIFIED="2008-08-15 10:50:04 -0400" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>Craven PD, Badawi N, Henderson-Smart DJ, O'Brien M</AU>
<TI>Regional (spinal, epidural, caudal) versus general anaesthesia in preterm infants undergoing inguinal herniorrhaphy in early infancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>4</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2008-08-15 10:49:51 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-08-15 10:49:51 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003669"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Henderson_x002d_Smart-a" MODIFIED="2011-01-20 23:37:26 -0500" MODIFIED_BY="[Empty name]" NAME="Henderson-Smart a" NOTES="&lt;p&gt;Henderson-Smart DJ , Steer P. Methylxanthine treatment for apnea in preterm infants. Cochrane Library 2008, Issue 4. Chichester, UK: John Wiley &amp;amp; Sons, Ltd.&lt;/p&gt;" NOTES_MODIFIED="2011-01-20 23:37:26 -0500" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>Henderson-Smart DJ , Steer P</AU>
<TI>Methylxanthine treatment for apnoea in preterm infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>12</NO>
<PB>Update software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2011-01-20 23:37:26 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-01-20 23:37:26 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000140"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Henderson_x002d_Smart-b" MODIFIED="2011-01-20 23:49:30 -0500" MODIFIED_BY="[Empty name]" NAME="Henderson-Smart b" NOTES="&lt;p&gt;Chichester, UK: John Wiley &amp;amp; Sons, Ltd.&lt;/p&gt;" NOTES_MODIFIED="2011-01-20 23:49:30 -0500" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>Henderson-Smart DJ, Davis PG</AU>
<TI>Prophylactic methylxanthine for extubation in preterm infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>12</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2011-01-20 23:49:30 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-01-20 23:49:30 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000139"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Henderson_x002d_Smart-c" MODIFIED="2011-01-20 23:42:47 -0500" MODIFIED_BY="[Empty name]" NAME="Henderson-Smart c" NOTES="&lt;p&gt;Chichester, UK: John Wiley &amp;amp; Sons, Ltd.&lt;/p&gt;" NOTES_MODIFIED="2011-01-20 23:42:47 -0500" NOTES_MODIFIED_BY="[Empty name]" TYPE="COCHRANE_REVIEW">
<AU>Henderson-Smart DJ, Steer PA</AU>
<TI>Prophylactic methylxanthine for preventing of apnoea in preterm infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>12</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2011-01-20 23:39:08 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-01-20 23:39:08 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000432"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Henderson_x002d_Smart-d" MODIFIED="2011-01-20 23:43:24 -0500" MODIFIED_BY="[Empty name]" NAME="Henderson-Smart d" TYPE="COCHRANE_REVIEW">
<AU>Henderson-Smart DJ, Steer PA</AU>
<TI>Caffeine versus theophylline for apnoea in preterm infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>1</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2011-01-20 23:43:24 -0500" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-01-20 23:43:24 -0500" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000273"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2011-06-15 10:59:10 -0400" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]</TI>
<SO>The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Krane-1995" MODIFIED="2011-06-15 10:59:26 -0400" MODIFIED_BY="[Empty name]" NAME="Krane 1995" TYPE="JOURNAL_ARTICLE">
<AU>Krane EJ, Haberkern CM, Jacobson LE</AU>
<TI>Postoperative apnea, bradycardia, and oxygen desaturation in formerly preterm infants: prospective comparison of spinal and general anesthesia</TI>
<SO>Anesthesia and Analgesia</SO>
<YR>1995</YR>
<VL>80</VL>
<PG>7-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Liu-1983" NAME="Liu 1983" NOTES="&lt;p&gt;Liu LM, Cote CJ, Goudsouzian NG, Ryan JF, Firestone S, Dedrick DF, Liu PL, Todres ID. Life-threatening apnea in infants recovering from anesthesia. Anesthesiology 1983, 59:506-510.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Liu LM, Cote CJ, Goudsouzian NG, Ryan JF, Firestone S, Dedrick DF, Liu PL, Todres ID</AU>
<TI>Life-threatening apnea in infants recovering from anesthesia</TI>
<SO>Anesthesiology</SO>
<YR>1983</YR>
<VL>59</VL>
<PG>506-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sale-2006" MODIFIED="2011-03-28 20:09:05 -0400" MODIFIED_BY="[Empty name]" NAME="Sale 2006" TYPE="JOURNAL_ARTICLE">
<AU>Sale SM, Read JA, Stoddart PA and Wolf AR</AU>
<TI>Prospective comparison of sevoflurane and desflurane in formerly premature infants undergoing inguinal herniotomy</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2006</YR>
<VL>96</VL>
<PG>774&#8211;778</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Spear-1992" NAME="Spear 1992" NOTES="&lt;p&gt;Spear RM. Anesthesia for premature and term infants: perioperative complications. J Pediatrics 1992, 120:165-176.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Spear RM</AU>
<TI>Anesthesia for premature and term infants: perioperative complications</TI>
<SO>Journal of Pediatrics</SO>
<YR>1992</YR>
<VL>120</VL>
<PG>165-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Welborn-1990" NAME="Welborn 1990" NOTES="&lt;p&gt;Welborn LG. Rice LJ. Hannallah RS. Broadman LM. Ruttimann UE. Fink R. Postoperative apnea in former preterm&lt;br&gt;infants: prospective comparison of spinal and general anesthesia. Anesthesiology. 72(5):838-42, 1990&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Welborn LG, Rice LJ, Hannallah RS, Broadman LM, Ruttimann UE, Fink R</AU>
<TI>Postoperative apnea in former preterm infants: prospective comparison of spinal and general anesthesia</TI>
<SO>Anesthesiology</SO>
<YR>1990</YR>
<VL>72</VL>
<PG>838-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Welborn-1994" NAME="Welborn 1994" NOTES="&lt;p&gt;Welborn LG. Greenspun JC. Anesthesia and apnea. Perioperative considerations in the former preterm infant. Pediatric Clinics of North America. 41(1):181-98, 1994&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Welborn LG, Greenspun JC</AU>
<TI>Anesthesia and apnea. Perioperative considerations in the former preterm infant</TI>
<SO>Pediatr Clin North Amer</SO>
<YR>1994</YR>
<VL>41</VL>
<PG>181-98</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2011-03-28 09:14:39 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Henderson_x002d_Smart-2001" MODIFIED="2011-03-28 09:14:39 -0400" MODIFIED_BY="[Empty name]" NAME="Henderson-Smart 2001" TYPE="COCHRANE_REVIEW">
<AU>Henderson-Smart DJ, Steer PA</AU>
<TI>Prophylactic caffeine to prevent postoperative apnea in preterm infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>2</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2011-03-28 09:14:39 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-03-28 09:14:39 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000048"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Henderson_x002d_Smart-2004" MODIFIED="2008-07-31 07:01:38 -0400" MODIFIED_BY="[Empty name]" NAME="Henderson-Smart 2004" TYPE="COCHRANE_REVIEW">
<AU>Henderson-Smart DJ, Steer PA</AU>
<TI>Prophylactic caffeine to prevent postoperative apnea in preterm infants</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2008-07-31 07:01:38 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2008-07-31 07:01:38 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000048"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2011-03-28 20:42:37 -0400" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2011-03-28 20:42:37 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2011-01-19 04:27:19 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-LeBard-1989">
<CHAR_METHODS>
<P>Randomisation method not specified, blinded treatment, blinding of assessment and exclusions not specified.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-01-19 04:26:04 -0500" MODIFIED_BY="[Empty name]">
<P>Preterm infants undergoing general anaesthesia.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-01-19 04:26:06 -0500" MODIFIED_BY="[Empty name]">
<P>Caffeine 10 mg/kg vs saline placebo IV after induction of anaesthesia.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-19 04:27:19 -0500" MODIFIED_BY="[Empty name]">
<P>Apnea &gt; 15 sec or with bradycardia &lt; 80 bpm, oxygen desaturations &lt;90% on pulse oximetry.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Abstract only available.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-19 04:28:18 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Welborn-1988">
<CHAR_METHODS MODIFIED="2011-01-19 04:28:09 -0500" MODIFIED_BY="[Empty name]">
<P>Randomly assigned by pharmacy, double blind, blind assessment of continuous recordings of apnoea/bradycardia, no exclusions mentioned.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-01-19 04:28:15 -0500" MODIFIED_BY="[Empty name]">
<P>Preterm (&lt;38 weeks gestational age) undergoing general anaesthesia for inguinal hernia repair at 35 - 44 weeks post menstrual age. Infants ineligible if existing cardiac, neurological or metabolic disease.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-01-19 04:28:18 -0500" MODIFIED_BY="[Empty name]">
<P>Caffeine 5 mg/kg vs saline placebo IV with induction of anaesthesia.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Apnea &gt;15 sec and/or bradycardia &lt;100 bmp for 5 sec.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-01-20 23:26:47 -0500" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Welborn-1989">
<CHAR_METHODS MODIFIED="2011-01-20 23:26:31 -0500" MODIFIED_BY="[Empty name]">
<P>Randomly assigned by pharmacy, double blind, blind assessment of continuous recordings of apnoea/bradycardia, no exclusions mentioned.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-01-20 23:26:47 -0500" MODIFIED_BY="[Empty name]">
<P>Preterm (&lt;38 weeks gestational age) undergoing general anaesthesia for inguinal hernia repair at 35 - 44 weeks post menstrual age. Infants ineligible if existing cardiac, neurological or metabolic disease.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-01-20 23:26:43 -0500" MODIFIED_BY="[Empty name]">
<P>Caffeine 10 mg/kg vs saline placebo IV with induction of anaesthesia.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-20 23:25:25 -0500" MODIFIED_BY="[Empty name]">
<P>Apnea &gt;15 sec and/or bradycardia &lt;100 bmp for 5 sec, oxygen desaturation &lt;90% during 12 hours post anaesthesia.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2011-03-28 20:42:37 -0400" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2011-01-19 04:30:58 -0500" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-19 04:25:00 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-LeBard-1989">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Welborn-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-19 04:30:58 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Welborn-1989">
<DESCRIPTION>
<P>Yes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2011-03-28 20:42:37 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-28 20:41:24 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-LeBard-1989">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-28 20:42:15 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Welborn-1988">
<DESCRIPTION>
<P>Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-28 20:42:37 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Welborn-1989">
<DESCRIPTION>
<P>Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2011-01-19 04:30:43 -0500" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-19 04:24:53 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-LeBard-1989">
<DESCRIPTION>
<P>Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-19 04:28:39 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Welborn-1988">
<DESCRIPTION>
<P>Yes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-01-19 04:30:43 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Welborn-1989">
<DESCRIPTION>
<P>Yes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2011-01-19 04:30:38 -0500" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-19 04:25:28 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-LeBard-1989">
<DESCRIPTION>
<P>No</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-19 04:29:12 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Welborn-1988">
<DESCRIPTION>
<P>No</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-19 04:30:38 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Welborn-1989">
<DESCRIPTION>
<P>No</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2011-01-19 04:30:33 -0500" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-19 04:25:51 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-LeBard-1989">
<DESCRIPTION>
<P>Only reported as abstract</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-19 04:29:19 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Welborn-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-19 04:30:33 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Welborn-1989">
<DESCRIPTION>
<P>Yes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2011-01-19 04:30:28 -0500" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-LeBard-1989">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-19 04:29:27 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Welborn-1988">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-19 04:30:28 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Welborn-1989">
<DESCRIPTION>
<P>No</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2011-06-05 17:44:19 -0400" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2011-06-05 17:44:19 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Caffeine vs placebo with induction of general anesthesia</NAME>
<DICH_OUTCOME CHI2="2.066351530075313" CI_END="0.34419584079372423" CI_START="0.0231992391792104" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.08935928398920301" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="25" I2="3.211047544891584" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.463194381920278" LOG_CI_START="-1.6345262575956805" LOG_EFFECT_SIZE="-1.0488603197579793" METHOD="MH" MODIFIED="2011-06-05 17:44:19 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3558751386126001" P_Q="1.0" P_Z="4.479887032664995E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="36" TOTAL_2="42" WEIGHT="100.00000000000001" Z="3.510070022389597">
<NAME>Postoperative apnoea/bradycardia</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="2.644275987477915" CI_START="0.04395116425623613" EFFECT_SIZE="0.3409090909090909" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.4223067812158454" LOG_CI_START="-1.3570296160768578" LOG_EFFECT_SIZE="-0.46736141743050624" ORDER="32" O_E="0.0" SE="1.0451910076269517" STUDY_ID="STD-LeBard-1989" TOTAL_1="11" TOTAL_2="15" VAR="1.0924242424242425" WEIGHT="13.751953402471942"/>
<DICH_DATA CI_END="1.0779040184891313" CI_START="0.004622581302667221" EFFECT_SIZE="0.07058823529411765" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="0.032580091002521586" LOG_CI_START="-2.3351154416638193" LOG_EFFECT_SIZE="-1.151267675330649" ORDER="33" O_E="0.0" SE="1.3907960761701177" STUDY_ID="STD-Welborn-1988" TOTAL_1="9" TOTAL_2="11" VAR="1.934313725490196" WEIGHT="31.396505185395657"/>
<DICH_DATA CI_END="0.5744228554706208" CI_START="0.0023880353983460377" EFFECT_SIZE="0.037037037037037035" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="13" LOG_CI_END="-0.24076828846057072" LOG_CI_START="-2.621959239857404" LOG_EFFECT_SIZE="-1.4313637641589874" ORDER="34" O_E="0.0" SE="1.3987233519358089" STUDY_ID="STD-Welborn-1989" TOTAL_1="16" TOTAL_2="16" VAR="1.9564270152505447" WEIGHT="54.85154141213241"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.8415039801333365" CI_END="0.6272913207030629" CI_START="0.026903677291444356" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.1299093655589124" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-0.2025307213847815" LOG_CI_START="-1.5701883550074829" LOG_EFFECT_SIZE="-0.8863595381961322" METHOD="MH" NO="2" P_CHI2="0.35896706026603564" P_Q="1.0" P_Z="0.011070998947039744" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="27" TOTAL_2="31" WEIGHT="100.0" Z="2.540449787299952">
<NAME>Postoperative oxygen desaturations</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="2.017429466421714" CI_START="0.03686878105393357" EFFECT_SIZE="0.2727272727272727" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.30479835981080305" LOG_CI_START="-1.4333412206879281" LOG_EFFECT_SIZE="-0.5642714304385626" ORDER="35" O_E="0.0" SE="1.0209917935146406" STUDY_ID="STD-LeBard-1989" TOTAL_1="11" TOTAL_2="15" VAR="1.0424242424242425" WEIGHT="33.23262839879154"/>
<DICH_DATA CI_END="0.9404416295699848" CI_START="0.0036793433038889633" EFFECT_SIZE="0.058823529411764705" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="8" LOG_CI_END="-0.02666815465091655" LOG_CI_START="-2.4342296881056313" LOG_EFFECT_SIZE="-1.2304489213782739" ORDER="36" O_E="0.0" SE="1.4142135623730951" STUDY_ID="STD-Welborn-1989" TOTAL_1="16" TOTAL_2="16" VAR="2.0000000000000004" WEIGHT="66.76737160120847"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>